Gaps in Accessibility of Pediatric Formulations: A Cross-Sectional Observational Study of a Teaching Hospital in Northern Thailand
- PMID: 35327673
- PMCID: PMC8947278
- DOI: 10.3390/children9030301
Gaps in Accessibility of Pediatric Formulations: A Cross-Sectional Observational Study of a Teaching Hospital in Northern Thailand
Abstract
The lack of appropriate medicines for children has a significant impact on health care practices in various countries around the world, including Thailand. The unavailability of pediatric medicines in hospital formularies causes issues regarding off-label use and extemporaneous preparation, resulting in safety and quality risks relating to the use of medicines among children. This research aimed to identify missing pediatric formulations based on the experience of healthcare professionals in a teaching hospital in northern Thailand. A cross-sectional survey was conducted to collect data on missing pediatric formulations, the reasons for their inaccessibility, their off-label uses, their reactions to the situation, and suggestions to improve access to these identified medications. The survey was distributed to all physicians, nurses, and pharmacists involved in prescribing, preparing, dispensing, and administering pediatric medicines. A total of 218 subjects responded to the survey. Omeprazole, sildenafil, and spironolactone suspension were most often identified as missing formulations for children by physicians and pharmacists. They are unavailable on the Thai market or in any hospital formulary. For nurses, sodium bicarbonate, potassium chloride, and chloral hydrate were the most problematic formulations in terms of preparation, acceptability, and administration. These medicines were difficult to swallow because of their taste or texture.
Keywords: acceptability; accessibility; availability; children; extemporaneous; national medicine list; off-label; pediatric formulation; quality.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Perceptions and attitudes towards off-label dispensing for pediatric patients, a study of hospital based pharmacists in Jordan.Saudi Pharm J. 2018 Jan;26(1):20-24. doi: 10.1016/j.jsps.2017.11.004. Epub 2017 Nov 13. Saudi Pharm J. 2018. PMID: 29379329 Free PMC article.
-
Pediatric oral extemporaneous preparations and practices: International Pharmaceutical Federation (FIP) global study.Eur J Pharm Biopharm. 2024 Nov;204:114483. doi: 10.1016/j.ejpb.2024.114483. Epub 2024 Sep 6. Eur J Pharm Biopharm. 2024. PMID: 39245358
-
Problems with oral formulations prescribed to children: a focus group study of healthcare professionals.Int J Clin Pharm. 2015 Dec;37(6):1057-67. doi: 10.1007/s11096-015-0152-x. Epub 2015 Jul 15. Int J Clin Pharm. 2015. PMID: 26173937
-
Eunice Kennedy Shriver National Institute of Child Health and Human Development Pediatrics Formulation Initiative: proceedings from the Second Workshop on Pediatric Formulations.Clin Ther. 2012 Nov;34(11):S1-10. doi: 10.1016/j.clinthera.2012.09.013. Clin Ther. 2012. PMID: 23149008
-
Pediatric drug formulations: a review of challenges and progress.Pediatrics. 2014 Aug;134(2):361-72. doi: 10.1542/peds.2013-3225. Epub 2014 Jul 14. Pediatrics. 2014. PMID: 25022739 Review.
Cited by
-
Systems Challenges in Accessing Medicines among Children under Thailand's Universal Health Coverage: A Qualitative Study of a Provincial Public Hospital Network.Children (Basel). 2022 Apr 13;9(4):552. doi: 10.3390/children9040552. Children (Basel). 2022. PMID: 35455597 Free PMC article.
-
Development and evaluation of an assessment of the age-appropriateness/inappropriateness of formulations used in children.Int J Clin Pharm. 2022 Dec;44(6):1394-1405. doi: 10.1007/s11096-022-01478-5. Epub 2022 Oct 8. Int J Clin Pharm. 2022. PMID: 36208398 Free PMC article.
-
Prevalence, Risk, and Challenges of Extemporaneous Preparation for Pediatric Patients in Developing Nations: A Review.Pharmaceutics. 2023 Mar 4;15(3):840. doi: 10.3390/pharmaceutics15030840. Pharmaceutics. 2023. PMID: 36986701 Free PMC article. Review.
-
Optimisation of the Manufacturing Process of Organic-Solvent-Free Omeprazole Enteric Pellets for the Paediatric Population: Full Factorial Design.Pharmaceutics. 2023 Nov 4;15(11):2587. doi: 10.3390/pharmaceutics15112587. Pharmaceutics. 2023. PMID: 38004567 Free PMC article.
-
Application of Galenic Strategies for Developing Gastro-Resistant Omeprazole Formulation for Pediatrics.Children (Basel). 2024 Aug 5;11(8):945. doi: 10.3390/children11080945. Children (Basel). 2024. PMID: 39201880 Free PMC article.
References
-
- Coelho H.L.L., Rey L.C., de Medeiros M.S.G., Barbosa R.A., da Cruz Fonseca S.G., da Costa P.Q. A critical comparison between the World Health Organization list of essential medicines for children and the Brazilian list of essential medicines (Rename) J. Pediatr. 2013;89:171–178. doi: 10.1016/j.jped.2013.03.004. - DOI - PubMed
-
- European Medicines Agency . Reflection Paper: Formulations of Choice for the Peadiatric Population. European Medicines Agency; London, UK: 2006.
-
- World Health Organization . Promoting Safety of Medicines for Children. World Health Organization; Geneva, Switzerland: 2007.
LinkOut - more resources
Full Text Sources